|
|
 |
|
|
|
|
Committee: Senate Committee on Health, Education, Labor and
Pensions |
|
|
Title: OxyContin: Balancing
Risks and Benefits |
|
|
Date: February 12, 2002 |
|
|
Place: Dirksen 430 |
|
|
 |
|
|
Publication:
|
|
|
Hearing File:
Click Here to view the final
hearing transcript as printed |
|
|
|
|
|
 |
|
|
Member
Statements |
|
|
 Senator
Edward M. Kennedy
 |
Susan Collins
|
|
Senator
Jack Reed
|
|
|
|
|
|
|
|
|
|
|
Witness
Testimony |
|
|
 |
John K. Jenkins, M.D.
|
|
|
H. Wesley Clark, M.D.,
M.P.H., J.D.
|
|
|
Richard Payne, M.D.
|
|
|
Art van Zee, M.D.
|
|
|
Nancy Green, C.N.M.
|
|
|
Lieutenant William R. Bess,
J.D.
|
|
|
Paul D. Goldenheim, M.D.
|
|
|
|
|
Statements
Submitted for the Record |
|
|
|
Representative Dave Weldon
|
|
|
Senator Jim Bunning
|
|
|
John D. Giglo, M.A., J.D.
|
|
|
Charlene Cowley, M.S.
|
|
|
DEA and 21 Health
Organizations
|
|
|
Carlos Ortiz
|
|
|
Glen R. Hanson, Ph.D., D.D.S.
|
|
|
National Association of
Chain Drug Stores
|
|
|
Oncology Nursing Society
|
|
|
Russell K. Portenoy, M.D.
|
|
|
Christopher Heye, Ph.D.
|
|
|
|
|
|
Click Here
to download Adobe Reader |
|
|
| |
